Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 188.00
-0.50 (-0.27%)
Aug 7, 2026, 1:30 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 49.54 billion as of August 7, 2026. Its market cap has decreased by -15.51% in one year.
Market Cap
49.54B
Enterprise Value
99.97B
Revenue
24.42B
Ranking
n/a
PE Ratio
12.78
Stock Price
188.00
ChartMarket Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 49.54B, an increase of 439.21%. That is a compound annual growth rate of 15.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 49.54B | -33.44% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 54.07B |
| Center Laboratories | 29.23B |
| TTY Biopharm Company | 19.05B |
| Synmosa Biopharma | 15.62B |
| ScinoPharm Taiwan | 15.34B |
| Handa Pharmaceuticals | 14.87B |
| YungShin Global Holding | 14.06B |
| Grape King Bio | 13.14B |